Medtronic has launched an exchange offer allowing its shareholders to swap their Medtronic shares for MiniMed Group shares at a 7% discount, expected to be tax-free for U.S. federal income tax purposes. MiniMed, formerly Medtronic's Diabetes business, went public in March 2026 with Medtronic retaining about 90% ownership. This move aims to spin off at least 80.1% of MiniMed shares, enabling MiniMed to operate independently and allowing Medtronic to focus on its Cardiovascular, Neuroscience, and Surgical divisions. The offer is voluntary, with conditions including a minimum number of shares tendered and legal tax opinions, and is expected to conclude around October 9, 2026.
Medtronic announced that its Stealth AXiS™ surgical system and Corsano™ multi-parameter wearable have been named to the TIME Best Inventions of 2026 list. The Stealth AXiS™ integrates planning, navigation, and robotic-assisted surgery into one platfo...
MiniMed announced its new Board of Directors following its separation from Medtronic, marking its start as an independent public company focused on diabetes technology. The board includes experts in healthcare, medtech, manufacturing, and governance,...
Procter & Gamble leads with 70 consecutive years of dividend increases, joined by T. Rowe Price, Cisco Systems, Medtronic, and Johnson & Johnson, all known for steady dividend growth backed by strong cash flow. These companies maintain payout ratios ...
Medtronic, Becton Dickinson, and Abbott Laboratories are three healthcare stocks with modest yields that have consistently raised dividends for decades, even through economic downturns. Medtronic is nearing 50 years of dividend increases with a 3.06%...
MiniMed has officially separated from Medtronic, marking its first day as an independent company focused on advancing diabetes care. Medtronic exchanged its shares for MiniMed stock and no longer holds equity in MiniMed. This independence allows Mini...
